- Home
- MREO vs INDO Comparison
MREO vs INDO Comparison
Compare MREO & INDO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | MREO | INDO |
|---|---|---|
| Founded | 2015 | 2018 |
| Country | United Kingdom | Indonesia |
| Employees | N/A | 81 |
| Industry | Biotechnology: Pharmaceutical Preparations | Oil & Gas Production |
| Sector | Health Care | Energy |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 52.5M | 47.2M |
| IPO Year | 2017 | 2018 |
Fundamental Metrics
Financial Performance| Metric | MREO | INDO |
|---|---|---|
| Price | $0.29 | $3.11 |
| Analyst Decision | Buy | |
| Analyst Count | 5 | 0 |
| Target Price | ★ $1.50 | N/A |
| AVG Volume (30 Days) | ★ 1.5M | 604.5K |
| Earning Date | 05-11-2026 | 05-13-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 16.67 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $500,000.00 | N/A |
| Revenue This Year | $5,184.20 | N/A |
| Revenue Next Year | $55.51 | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.20 | $2.40 |
| 52 Week High | $2.94 | $8.50 |
Technical Indicators
Market Signals| Indicator | MREO | INDO |
|---|---|---|
| Relative Strength Index (RSI) | 54.99 | 45.70 |
| Support Level | $0.21 | $2.74 |
| Resistance Level | $0.36 | $3.33 |
| Average True Range (ATR) | 0.03 | 0.18 |
| MACD | 0.00 | 0.02 |
| Stochastic Oscillator | 94.74 | 46.72 |
Price Performance
Historical ComparisonAbout MREO Mereo BioPharma Group plc
Mereo BioPharma Group PLC is a United Kingdom (U.K.) based biopharmaceutical company focused on the development of therapeutics for rare diseases. The company has developed a portfolio of late-stage clinical product candidates, and its two rare disease product candidates are setrusumab for the treatment of osteogenesis imperfecta (OI) and alvelestat, mainly for the treatment of severe alpha-1 antitrypsin deficiency-associated lung disease (AATD-LD).
About INDO Indonesia Energy Corporation Limited
Indonesia Energy Corp Ltd is an oil and gas exploration and production company focused on Indonesia. The company is an independent energy company engaged in the oil and gas business and holds two oil and gas assets through its subsidiaries in Indonesia: The Kruh Block and the Citarum Block. It has also identified a potential third exploration block known as the Rangkas area. . Its portfolio consists of Kruh Block and Citarum Block. The company generates its revenue from oil and gas sales.